RayVio has developed its unique ultraviolet LED technology, which can protect against germs in water, surfaces and air with flexible applications from automated surface and air disinfection to point-of-use water treatment.
“Consumers in too many countries lack control over major environmental health risks that lurk in everything from drinking water to hospital care,” said RayVio’s chief executive Dr. Robert C. Walker.
As existing cleaning solutions are often ineffective, it claims that more than 3.4 million people die every year from water-related diseases and one in 25 hospital patients have suffered from at least one healthcare-associated infection.
The funding will be used to expand its world-class manufacturing frontend and backend capacity and double its workforce, while continuing to deliver on its leading product performance roadmap through research and development. It is also expanding its global sales and marketing capabilities, application support and distribution channels.
“RayVio is poised to transform daily life in places like China, where residents often lack access to basic necessities like safe water and hospitals,” said Alex Banh of IPV Capital.
“RayVio’s proven technology and deep domain expertise are second to none,” said Don Ye, founder and managing partner of Tsing Capital. “The company is enabling a new ecosystem of consumer disinfection products that were never possible before.”
With the new funding, both Alex Banh and Don Ye will join the board of directors.